KKR Acquires Controlling Stake in Indian Healthcare Provider HCG for $400 Million

Mumbai, India - On February 23, 2025, it was announced that KKR, a global investment firm, has acquired a controlling stake in Healthcare Global Enterprises (HCG), a leading healthcare organization in India. This acquisition, valued at $400 million, makes KKR the largest and controlling shareholder of HCG. The investment will allow HCG to expand its reach in providing cancer care in India. KKR's investment was made through its Asia Fund IV and marks their latest investment in India's healthcare sector. Past investments in this sector include Baby Memorial Hospital, Healthium, Infinx, Max Healthcare, JB, and Gland Pharma. Both KKR and HCG expressed excitement about the partnership and their shared vision of improving healthcare in India.

Healthcare Global Enterprises Ltd is a leading provider of cancer care and diagnostics, operating a network of specialized hospitals and healthcare facilities.

Top Hospital Stocks

Stock Name	MCap(Cr)	P/E Ratio	3Y Stock Ret.
Stock Name	MCap(Cr)	P/E Ratio	3Y Stock Ret.
Max Healthcare Institute Ltd NSE: MAXHEALTH	1,17,999	104.25	49.37%
Apollo Hospitals Enterprise Ltd NSE: APOLLOHOSP	1,01,562	70.24	23.09%
Fortis Healthcare Ltd NSE: FORTIS	57,018	67.65	48.81%
Narayana Hrudayalaya Ltd NSE: NH	38,898	48.84	44.23%
Global Health Ltd NSE: MEDANTA	30,390	58.62	-